The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review

BACKGROUND: COVID-19 vaccines are required for individuals with myasthenia gravis (MG), as these patients are more likely to experience severe pneumonia, myasthenia crises, and higher mortality rate. However, direct data on the safety of COVID-19 vaccines in patients with MG are lacking, which resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Siyang, Tian, Yukun, Meng, Linghao, Fang, Ruiying, Chang, Weiqian, Yang, Yajing, Li, Shaohong, Shen, Qiqi, Ni, Jinxia, Zhu, Wenzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812949/
https://www.ncbi.nlm.nih.gov/pubmed/36618419
http://dx.doi.org/10.3389/fimmu.2022.1103020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812949/
https://www.ncbi.nlm.nih.gov/pubmed/36618419
http://dx.doi.org/10.3389/fimmu.2022.1103020

Ejemplares similares